Abstract
The current trend toward the use of 125I seed rather than 60Co applicators in the treatment of ocular tumors stems largely from the extent to which photons from the two radionuclides are attenuated differently by plaque material on the one hand and by intraocular tissue on the other. The much lower energies of 125I photons from seeds in a rimmed gold plaque not only permit near-total elimination of radiation dose in orbital tissue adjacent to the plaque but also allow significant dose reduction to critical structures within the eye, relative to either 60Co plaque or proton beam reatment (Fairchild 1984). Although other photon-emitting radionuclides have been used in ophthalmic applicators (Luxton et al. 1988a), we will focus attention here on the physical characteristics of 60Co and 125I applicators because they have been the most widely used and because they illustrate well the pertinent differences between “high energy” and “low energy” photons for this type of brachytherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Astrahan M, Liggett P, Petrovich Z, Luxton G (1988) A 500 kHz localized current field hyperthermia system for use with ophthalmic plaque radiotherapy. Recent Results Cancer Res 107:93–98
Astrahan MA, Luxton G, Gabor J, Kampp TD, Liggett PE, Sapozink MD, Petrovich Z (1990) An interactive treatment planning system for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys 18:679–687
Beddoe AH (1972) Exposure distributions from 60Co ophthalmic applicator. Br J Radiol 45:157
Beddoe AH (1975) Isoexposure curves for 60Co ophthalmic applicators. Australas Radiol 19:145–151
Casebow MP (1971) The calculation and measurement of exposure distributions from 60Co ophthalmic applicators. Br J Radiol 44:618–624
Chan B, Rotman M, Randall GJ (1972) Computerized dosimetry of 60Co ophthalmic applicators. Radiology 103:705–707
Chiu-Tsao ST, O’Brien K, Sanna R et al. (1986) Monte Carlo dosimetry for 125I and 60Co in eye plaque therapy. Med Phys 13:678–682
Chiu-Tsao ST, Anderson LL, Stabile L (1988) TLD dosimetry for 125I eye plaque. Phys Med Biol 33 [Suppl 1]:128
Chiu-Tsao ST, Anderson LL, O’Brien K, Sanna R (1990) Dose rate determination for 125I seeds. Med Phys 17: 815–825
Coleman DJ, Lizzi FL, Burgess SEP et al. (1986) Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma. Am J Ophthalmol 101:635–642
Cygler J, Szanto J, Soubra M, Rogers DWO (1990) Effects of gold and silver backings on the dose rate around an 125I seed. Med Phys 17:172–178
Earle J, Kline RW, Robertson DM (1987) Selection of iodine 125 for the collaborative ocular melanoma study. Arch Ophthalmol 105:763–764
Fairchild RG (1984) New radiotherapeutic techniques in nuclear ophthalmology. Sem Nucl Med 14:35–45
Finger PT, Packer S, Svitra PP, Paglione RW, Anderson LL, Kim JH, Jacobiec FA (1985) Thermoradiotherapy for intraocular tumors. Arch Ophthalmol 103:1574–1578
Finger PT, Packer S, Paglione RW, Gatz JF, Ho TK, Bosworth JL (1989) Thermoradiotherapy of choroidal melanoma: clinical experience. Ophthalmology 96:1384–1388
Goitein M, Miller T (1983) Planning proton therapy of the eye. Med Phys 10:275–283
Harnett AN, Thomson ES (1988) An iodine-125 plaque for radiotherapy of the eye: manufacture and dosimetric considerations. Br J Radiol 61:835–838
Houdek PV, Schwade JG, Medina AJ et al. (1989) MR technique for localization and verification procedures in episcleral brachytherapy. Int J Radiat Oncol Biol Phys 17:1111–1114
Innes G (1962) The application of physics in the treatment of ocular neoplasms. In: Boniuk M (ed) Ocular and adnexal tumors. CV Mosby, St. Louis, p 142
Interstitial Collaborative Working Group: Anderson LL, Nath R, Weaver KA et al. (1990) Interstitial brachy-therapy: physical, biological and clinical considerations. Raven, New York
Karolis C, Amies C, Frost RB, Billson FA (1989) The development of a thin stainless steel eye plaque to treat tumours of the eye up to 15 mm in diameter. Australas Phys Eng Sci Med 12:172–177
Karolis C, Frost RB, Billson FA (1990) A thin I-125 seed eye plaque to treat intraocular tumors using an acrylic insert to precisely position the sources. Int J Radiat Oncol Biol Phys 18:1209–1213
Kepka AG, Johnson PM, Kline RW (1988) The generalized geometry of eye plaque therapy. Med Phys 15:375–379
Ling CC, Chen GT, Boothby JW et al. (1989) Computer assisted treatment planning for 125I ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys 17:405–410
Luxton G, Astrahan MA, Liggett PE, Neblett DL, Cohen DM, Petrovich Z (1988a) Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds. Int J Radiat Oncol Biol Phys 15:167–176
Luxton G, Astrahan MA, Petrovich Z (1988b) Backscatter measurements from a single seed of 125I for ophthalmic plaque dosimetry. Med Phys 15:397–400
Magnus L (1967) Tiefendosisberechnung für die 60Co-Augenapplikatoren CKA 1–4 (nach Stallard). Strahlentherapie 132:379–386
Magnus L, Göbbeler T, Strötges (1968) Tiefendosisberechnung für die 60Co-Augenapplikatoren CKA 5–11 (nach Stallard). Strahlentherapie 136:170–177
Magnus L, Göbbeler T, Rassow J, Strötges W (1969) Isodosenmessungen an den Kobalt-60-Augenapplikatoren (nach Stallard): die Isodosen bei den Applikatoren CKA 1–4. Radiol Clin Biol 38:213–227
Meisberger LJ, Keller RJ, Shalek RJ (1968) The effective attenuation in water of the gamma rays of gold 198, iridium 192, cesium 137, radium 226, and cobalt 60. Radiology 90:953–957
Packer S, Rotman M (1980) Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 87:582–590
Packer S, Fairchild RG, Salanitro P (1987) New techniques for iodine-125 radiotherapy of intraocular tumors. Ann Ophthalmol 19:26–30
Rassow J, Strüter H-D, Magnus L, Göbbeler T (1970) Isodosenmessungen an den Kobalt-60-Augenapplikatoren (nach Stallard): allgemeine Berechnung der Tiefendosis für kreisförmige Flächenaktivitäten und die Messung der Isodosen für die Applikatoren CKA 8–11. Radiol Clin Biol 39:32–46
Schell MC, Weaver KA, Phillips TL, Char DH, Quivey JM, Barnett C, Ling CC (1989) Design of iodine-125 eye plaques for radiation therapy. Endocurietherapy/ Hyperthermia Oncology 5:83–90
Sealy R, le Roux PLM, Rapley F, Hering E, Shackleton D, Sevel D (1976) The treatment of ophthalmic tumours with low-energy sources. Br J Radiol 49:551–554
Sealy R, Buret E, Cleminshaw H et al. (1980) Progress in the use of iodine therapy for tumours of the eye. Br J Radiol 53:1052–1060
Task Group 32: Nath R, Anderson L, Jones D, Ling C, Loevinger R, Williamson J, Hanson W (1987) Specification of brachytherapy source strength, AAPM Report No. 21. American Institute of Physics, New York
Weaver KA (1986) The dosimetry of 125I seed eye plaques. Med Phys 13:78–83
Wu A, Sternick ES, Muise DJ (1988) Effect of gold shielding on the dosimetry of an 125I seed at close range. Med Phys 15:627–628
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Anderson, L.L., Chiu-Tsao, ST. (1993). Physical Aspects of Eye Plaque Brachytherapy Using Photon Emitters. In: Alberti, W.E., Sagerman, R.H. (eds) Radiotherapy of Intraocular and Orbital Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97011-5_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-97011-5_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97013-9
Online ISBN: 978-3-642-97011-5
eBook Packages: Springer Book Archive